Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Trodelvy
Pharma
Gilead bolsters Trodelvy with first-line breast cancer win
An ASCO expert called Trodelvy and Keytruda's 35% improvement on progression-free survival in first-line PD-L1-positive TNBC practice-changing.
Angus Liu
May 31, 2025 8:00am
Gilead's Trodelvy chalks up another phase 3 breast cancer win
May 23, 2025 10:10am
Daiichi Sankyo reports solid launch for touted ADC Datroway
Apr 28, 2025 5:00pm
Gilead's Trodelvy-Keytruda proposal hits goal in first-line TNBC
Apr 21, 2025 11:29am
AZ, Daiichi kick off busy 2025 with FDA nod for their 2nd ADC
Jan 17, 2025 9:14pm
AZ's Enhertu, Akeso's bispecifics win reimbursement in China
Dec 4, 2024 12:52pm
